On the back of the Opthea phase 3 trial results released this morning would be my best guess. Another example of how risky biotech investing can be
On the back of the Opthea phase 3 trial results released this...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.40 |
Change
0.070(1.62%) |
Mkt cap ! $1.426B | |||
| Open | High | Low | Value | Volume |
| $4.41 | $4.57 | $4.32 | $10.39M | 2.342M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 48646 | $4.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.41 | 1903 | 7 |
View Market Depth
| Last trade - 13.49pm 31/07/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |